X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PFIZER ALKEM LABORATORIES/
PFIZER
 
P/E (TTM) x - 23.4 - View Chart
P/BV x 6.2 3.7 167.9% View Chart
Dividend Yield % 0.7 0.9 79.7%  

Financials

 ALKEM LABORATORIES   PFIZER
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
PFIZER
Mar-16
ALKEM LABORATORIES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,5892,724 58.3%   
Low Rs1,2321,611 76.5%   
Sales per share (Unadj.) Rs417.5440.9 94.7%  
Earnings per share (Unadj.) Rs56.348.7 115.6%  
Cash flow per share (Unadj.) Rs64.775.8 85.4%  
Dividends per share (Unadj.) Rs12.7015.00 84.7%  
Dividend yield (eoy) %0.90.7 130.1%  
Book value per share (Unadj.) Rs292.9462.9 63.3%  
Shares outstanding (eoy) m119.5745.75 261.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.9 68.7%   
Avg P/E ratio x25.144.5 56.3%  
P/CF ratio (eoy) x21.828.6 76.2%  
Price / Book Value ratio x4.84.7 102.8%  
Dividend payout %22.630.8 73.2%   
Avg Mkt Cap Rs m168,65399,163 170.1%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m9,1712,758 332.6%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m49,91520,170 247.5%  
Other income Rs m1,645857 191.9%   
Total revenues Rs m51,56121,028 245.2%   
Gross profit Rs m8,4824,310 196.8%  
Depreciation Rs m1,0061,239 81.2%   
Interest Rs m6715 12,896.2%   
Profit before tax Rs m8,4513,923 215.4%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m1,6061,794 89.5%   
Profit after tax Rs m6,7312,228 302.1%  
Gross profit margin %17.021.4 79.5%  
Effective tax rate %19.045.7 41.5%   
Net profit margin %13.511.0 122.1%  
BALANCE SHEET DATA
Current assets Rs m27,06216,299 166.0%   
Current liabilities Rs m15,3247,594 201.8%   
Net working cap to sales %23.543.2 54.5%  
Current ratio x1.82.1 82.3%  
Inventory Days Days6765 101.9%  
Debtors Days Days4126 160.3%  
Net fixed assets Rs m12,6108,622 146.2%   
Share capital Rs m239458 52.3%   
"Free" reserves Rs m34,49020,722 166.4%   
Net worth Rs m35,02721,180 165.4%   
Long term debt Rs m1,21225 4,846.4%   
Total assets Rs m54,38729,137 186.7%  
Interest coverage x13.6755.5 1.8%   
Debt to equity ratio x00 2,930.5%  
Sales to assets ratio x0.90.7 132.6%   
Return on assets %13.67.7 177.6%  
Return on equity %19.210.5 182.7%  
Return on capital %24.919.0 130.9%  
Exports to sales %12.90.1 21,757.1%   
Imports to sales %3.117.5 17.7%   
Exports (fob) Rs m6,46112 53,842.5%   
Imports (cif) Rs m1,5403,526 43.7%   
Fx inflow Rs m6,56352 12,707.3%   
Fx outflow Rs m3,012140 2,151.5%   
Net fx Rs m3,552-88 -4,020.8%   
CASH FLOW
From Operations Rs m7,2593,436 211.2%  
From Investments Rs m1,864-6,991 -26.7%  
From Financial Activity Rs m-9,273-619 1,498.5%  
Net Cashflow Rs m-150-4,174 3.6%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 33.1 7.5 441.3%  
FIIs % 0.0 4.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 23.7 -  
Shareholders   68,381 85,207 80.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends in Red on Diwali Day; Bank & Metal Stocks Fall(Closing)

The hour-long auspicious Muhurat trading session ended on a weak note today. While the BSE Sensex closed lower by about 194 points.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

25 Things PM Modi Did Not Tell You About the Indian Economy(Vivek Kaul's Diary)

Oct 9, 2017

There are way too many data points out there which clearly show that all is not well with the Indian economy.

Electric Vehicles Boom: Stocks to Watch Out For(Smart Contrarian)

Oct 9, 2017

Are you creating a watch list of stocks for participating in the coming electric vehicles boom?

Timeless Stocks on the Electric Car Assembly Line(The 5 Minute Wrapup)

Oct 10, 2017

Are they on their way to create Coca Cola-like wealth?

Mutual Funds Re-categorised... But What About Stocks?(Daily Profit Hunter)

Oct 11, 2017

The market regulator can solve systemic issues but you must tackle the behavioral biases on your own.

9 Common, Yet Vital Questions On Personal Finance Answered(Outside View)

Oct 13, 2017

The answers to these 9 questions act as thumb rules to streamline your personal finances.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 19, 2017 07:33 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS